Caribou Biosciences Announces Director Elections and Auditor Confirmation

Caribou Biosciences held its annual meeting, confirming the election of two Class I directors and the selection of Deloitte & Touche LLP as the independent auditor. Stockholders also approved an amendment to the company's certificate of incorporation to allow a reverse stock split. The company's financial challenges and declining revenues negatively impact its valuation, but a strong equity position provides some stability.